OCC
Click for more information
0.00% 37.0¢ orthocell limited

US FDA regarding the US regulatory pathway for Remplir™

  1. roughie12
    2,117 Posts.
    lightbulb Created with Sketch. 260
    clock Created with Sketch.
    22/03/22
    10:19
    Post #: 60335362
    Now the company has ticked the TGA box off the list we really need an update on the FDA approval for Nerve.

    From the quarterly comment below.

    Anyone spoken to management on when we should expect an update?

    Commenced interactions with the US FDA regarding the US regulatory pathway for Remplir™, data to support expedited review and reimbursement positioning.
    OCC Price at posting: 45.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Microcap Madness: 5 junior explorers with news out on Thursday 20 June
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
37.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $77.45M
Open High Low Value Volume
37.0¢ 37.0¢ 37.0¢ $53.87K 145.6K

Buyers (Bids)

No. Vol. Price($)
4 86513 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 37044 2
View Market Depth
Last trade - 14.00pm 24/06/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.